A Food and Drug Administration advisory committee last week recommendedapproval of Merck's Fosamax drug for the treatment of osteoporosis.If Fosamax is approved by the FDA, it is expected to give a boostto vendors of dual-energy x-ray absorptiometry
A Food and Drug Administration advisory committee last week recommendedapproval of Merck's Fosamax drug for the treatment of osteoporosis.If Fosamax is approved by the FDA, it is expected to give a boostto vendors of dual-energy x-ray absorptiometry (DEXA) scanners,such as Lunar and Hologic. Merck last month announced financingagreements with the companies to help promote sales of bone densitometrydevices (SCAN 7/6/95).
CMS Issues New Reimbursement Code for PSMA PET Agent POSLUMA
September 26th 2023The transitional pass-through payment reimbursement code for the FDA-approved PSMA PET agent for prostate cancer detection will be effective as of October 1, according to the Centers for Medicare and Medicare Services (CMS).
2 Clarke Drive
Cranbury, NJ 08512